机译:临床迹象,将休克和靶血管活性药物分类为温暖,冷儿科脓毒症休克*
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Drexel Univ Dornsife Sch Publ Hlth Dept Epidemiol &
Biostat Philadelphia PA 19104 USA;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Apollo Childrens Hosp Crit Care Chennai Tamil Nadu India;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
Univ Penn Childrens Hosp Philadelphia Dept Anesthesiol &
Crit Care Philadelphia PA 19104 USA;
cold shock; pediatric septic shock; vasoactive therapy; warm shock;
机译:多巴胺与肾上腺素作为小儿败血性休克一线血管活性药物的双盲前瞻性随机对照试验
机译:在儿科脓毒症休克中是否存在最佳的流体推注? “液体推注超过15-20分钟的临界评估,每次腐败的儿童复苏的第一个小时:Sankar等人(Pediastr Crit Care Med 2017; 18:E435-E445)的随机对照试验 的)
机译:在儿科脓毒症休克中是否存在最佳的流体推注? “液体推注超过15-20分钟的临界评估,每次腐败的儿童复苏的第一个小时:Sankar等人(Pediastr Crit Care Med 2017; 18:E435-E445)的随机对照试验 的)
机译:开发了一种用于定量血清锌的护理点设备,以帮助诊断和随访小儿败血性休克
机译:康涅狄格州成年和小儿患者的败血症和败血性休克流行病学
机译:早期目标控制等离子体体积的功效和安全性用平衡的明胶溶液对具有严重脓毒症/脓毒症休克患者的平衡电解质溶液:研究方案设计和理论的前瞻性随机控制双盲多中心国际临床试验:
机译:血管活性药物对脓毒症患者的比较疗效:随机对照试验的网络荟萃分析
机译:[中华创伤骨科杂志Chinese Journal of Orthopaedic Trauma]张莹莹,王莹,王莹,王莹,王莹,王玮 - 复发性血管内球囊阻塞主动脉(REBOa)治疗严重骨盆骨折和腹腔失血性休克的临床研究。